Health Canada
Symbol of the Government of Canada

Common menu bar links

Drugs and Health Products

Release of Draft (Step 2) International Council on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: E6 Integrated Addendum: Good Clinical Practice

Warning This content was archived on February 16, 2016.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

Notice to the reader: The online consultation is now closed.

The above referenced draft guidance was released by the ICH Steering Committee for consultation and is being posted on the Health Canada website for information and comment in accordance with Step 2 of the ICH process.

How to Get Involved

This consultation is open for comment starting November 25, 2015 until February 1, 2016. Please select and read through the link below titled "Consultation Document". Once read, please submit your comments via email, fax or by mail to:

Norman Viner
Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetic Therapies Directorate
Health Products and Food Branch
Health Canada
100 Eglantine Driveway, Tunney's Pasture
Ottawa, Ontario
K1A 0K9

Telephone: 613-293-1962
Facsimile: 613-952-2816

Consultation Document

Interested parties are encouraged to provide comments and suggestions by February 1, 2016.

Reporting to Canadians

Health Canada will make the results of this consultation available on this Web site.

If you have any questions, contact

Interested in our other consultations? Sign up and stay informed about topics that matter to you.